Case report: Indolent drug-related pneumonitis with alectinib therapy in the treatment of non-small cell lung cancer

• Main Authors: Xianmeng Chen (Author), Daqing Xia (Author), Xuqin Jiang (Author), Lejie Cao (Author), Jay H. Ryu (Author), Xiaowen Hu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Molecular targeting therapy is becoming the standard of care for some patients with anaplastic lymphoma kinase (ALK)-rearranged lung adenocarcinoma. Drug-related pneumonitis (DRP) has been identified as an infrequent but potentially severe adverse effect. Herein, we report a 50-year-old woman with A...